Interrogation of tumor biopsies from 122 patients before and after neoadjuvant chemotherapy revealed the expression level of ROR1 was increased in residual breast cancer cells after surgery and was associated with enhanced expression of genes associated with EMT, proliferation, and cancer stemness. The gene discussed is ROR1; the disease is breast carcinoma.